Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice

Abstract Background The use of probiotic lactic acid bacteria as a mucosal vaccine vector is considered a promising alternative compared to the use of other microorganisms because of its “Generally Regarded as Safe” status, its potential adjuvant properties, and its tolerogenicity to the host. Sever...

Full description

Bibliographic Details
Main Authors: In-Chan Hwang, Valerie Diane Valeriano, Ji Hoon Song, Marcela Pereira, Ju Kyoung Oh, Kyudong Han, Lars Engstrand, Dae-Kyung Kang
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Microbial Cell Factories
Subjects:
Online Access:https://doi.org/10.1186/s12934-023-02100-7
_version_ 1797827222488219648
author In-Chan Hwang
Valerie Diane Valeriano
Ji Hoon Song
Marcela Pereira
Ju Kyoung Oh
Kyudong Han
Lars Engstrand
Dae-Kyung Kang
author_facet In-Chan Hwang
Valerie Diane Valeriano
Ji Hoon Song
Marcela Pereira
Ju Kyoung Oh
Kyudong Han
Lars Engstrand
Dae-Kyung Kang
author_sort In-Chan Hwang
collection DOAJ
description Abstract Background The use of probiotic lactic acid bacteria as a mucosal vaccine vector is considered a promising alternative compared to the use of other microorganisms because of its “Generally Regarded as Safe” status, its potential adjuvant properties, and its tolerogenicity to the host. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease (COVID-19), is highly transmissible and pathogenic. This study aimed to determine the potential of Lactiplantibacillus plantarum expressing SARS-CoV-2 epitopes as a mucosal vaccine against SARS-CoV-2. Results In this study, the possible antigenic determinants of the spike (S1–1, S1–2, S1–3, and S1–4), membrane (ME1 and ME2), and envelope (E) proteins of SARS-CoV-2 were predicted, and recombinant L. plantarum strains surface-displaying these epitopes were constructed. Subsequently, the immune responses induced by these recombinant strains were compared in vitro and in vivo. Most surface-displayed epitopes induced pro-inflammatory cytokines [tumor necrosis factor alpha (TNF-α and interleukin (IL)-6] and anti-inflammatory cytokines (IL-10) in lipopolysaccharide-induced RAW 264.7, with the highest anti-inflammatory to pro-inflammatory cytokine ratio in the S1–1 and S1–2 groups, followed by that in the S1–3 group. When orally administered of recombinant L. plantarum expressing SARS-CoV-2 epitopes in mice, all epitopes most increased the expression of IL-4, along with induced levels of TNF-α, interferon-gamma, and IL-10, specifically in spike protein groups. Thus, the surface expression of epitopes from the spike S1 protein in L. plantarum showed potential immunoregulatory effects, suggesting its ability to potentially circumvent hyperinflammatory states relevant to monocyte/macrophage cell activation. At 35 days post immunization (dpi), serum IgG levels showed a marked increase in the S1–1, S1–2, and S1–3 groups. Fecal IgA levels increased significantly from 21 dpi in all the antigen groups, but the boosting effect after 35 dpi was explicitly observed in the S1–1, S1–2, and S1–3 groups. Thus, the oral administration of SARS-CoV-2 antigens into mice induced significant humoral and mucosal immune responses. Conclusion This study suggests that L. plantarum is a potential vector that can effectively deliver SARS-CoV-2 epitopes to intestinal mucosal sites and could serve as a novel approach for SARS-CoV-2 mucosal vaccine development.
first_indexed 2024-04-09T12:44:47Z
format Article
id doaj.art-162be1f5d7a942318cda29181a8e2ec6
institution Directory Open Access Journal
issn 1475-2859
language English
last_indexed 2024-04-09T12:44:47Z
publishDate 2023-05-01
publisher BMC
record_format Article
series Microbial Cell Factories
spelling doaj.art-162be1f5d7a942318cda29181a8e2ec62023-05-14T11:31:55ZengBMCMicrobial Cell Factories1475-28592023-05-0122111410.1186/s12934-023-02100-7Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in miceIn-Chan Hwang0Valerie Diane Valeriano1Ji Hoon Song2Marcela Pereira3Ju Kyoung Oh4Kyudong Han5Lars Engstrand6Dae-Kyung Kang7Department of Animal Resources Science, Dankook UniversityDepartment of Microbiology, Tumor and Cell Biology, Karolinska InstitutetDepartment of Animal Resources Science, Dankook UniversityDepartment of Microbiology, Tumor and Cell Biology, Karolinska InstitutetDepartment of Microbiology, Tumor and Cell Biology, Karolinska InstitutetDepartment of Microbiology, College of Science and Technology, Dankook UniversityDepartment of Microbiology, Tumor and Cell Biology, Karolinska InstitutetDepartment of Animal Resources Science, Dankook UniversityAbstract Background The use of probiotic lactic acid bacteria as a mucosal vaccine vector is considered a promising alternative compared to the use of other microorganisms because of its “Generally Regarded as Safe” status, its potential adjuvant properties, and its tolerogenicity to the host. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease (COVID-19), is highly transmissible and pathogenic. This study aimed to determine the potential of Lactiplantibacillus plantarum expressing SARS-CoV-2 epitopes as a mucosal vaccine against SARS-CoV-2. Results In this study, the possible antigenic determinants of the spike (S1–1, S1–2, S1–3, and S1–4), membrane (ME1 and ME2), and envelope (E) proteins of SARS-CoV-2 were predicted, and recombinant L. plantarum strains surface-displaying these epitopes were constructed. Subsequently, the immune responses induced by these recombinant strains were compared in vitro and in vivo. Most surface-displayed epitopes induced pro-inflammatory cytokines [tumor necrosis factor alpha (TNF-α and interleukin (IL)-6] and anti-inflammatory cytokines (IL-10) in lipopolysaccharide-induced RAW 264.7, with the highest anti-inflammatory to pro-inflammatory cytokine ratio in the S1–1 and S1–2 groups, followed by that in the S1–3 group. When orally administered of recombinant L. plantarum expressing SARS-CoV-2 epitopes in mice, all epitopes most increased the expression of IL-4, along with induced levels of TNF-α, interferon-gamma, and IL-10, specifically in spike protein groups. Thus, the surface expression of epitopes from the spike S1 protein in L. plantarum showed potential immunoregulatory effects, suggesting its ability to potentially circumvent hyperinflammatory states relevant to monocyte/macrophage cell activation. At 35 days post immunization (dpi), serum IgG levels showed a marked increase in the S1–1, S1–2, and S1–3 groups. Fecal IgA levels increased significantly from 21 dpi in all the antigen groups, but the boosting effect after 35 dpi was explicitly observed in the S1–1, S1–2, and S1–3 groups. Thus, the oral administration of SARS-CoV-2 antigens into mice induced significant humoral and mucosal immune responses. Conclusion This study suggests that L. plantarum is a potential vector that can effectively deliver SARS-CoV-2 epitopes to intestinal mucosal sites and could serve as a novel approach for SARS-CoV-2 mucosal vaccine development.https://doi.org/10.1186/s12934-023-02100-7Lactiplantibacillus plantarumSARS-CoV-2Mucosal delivery vectorOral vaccine
spellingShingle In-Chan Hwang
Valerie Diane Valeriano
Ji Hoon Song
Marcela Pereira
Ju Kyoung Oh
Kyudong Han
Lars Engstrand
Dae-Kyung Kang
Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice
Microbial Cell Factories
Lactiplantibacillus plantarum
SARS-CoV-2
Mucosal delivery vector
Oral vaccine
title Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice
title_full Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice
title_fullStr Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice
title_full_unstemmed Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice
title_short Mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice
title_sort mucosal immunization with lactiplantibacillus plantarum displaying recombinant sars cov 2 epitopes on the surface induces humoral and mucosal immune responses in mice
topic Lactiplantibacillus plantarum
SARS-CoV-2
Mucosal delivery vector
Oral vaccine
url https://doi.org/10.1186/s12934-023-02100-7
work_keys_str_mv AT inchanhwang mucosalimmunizationwithlactiplantibacillusplantarumdisplayingrecombinantsarscov2epitopesonthesurfaceinduceshumoralandmucosalimmuneresponsesinmice
AT valeriedianevaleriano mucosalimmunizationwithlactiplantibacillusplantarumdisplayingrecombinantsarscov2epitopesonthesurfaceinduceshumoralandmucosalimmuneresponsesinmice
AT jihoonsong mucosalimmunizationwithlactiplantibacillusplantarumdisplayingrecombinantsarscov2epitopesonthesurfaceinduceshumoralandmucosalimmuneresponsesinmice
AT marcelapereira mucosalimmunizationwithlactiplantibacillusplantarumdisplayingrecombinantsarscov2epitopesonthesurfaceinduceshumoralandmucosalimmuneresponsesinmice
AT jukyoungoh mucosalimmunizationwithlactiplantibacillusplantarumdisplayingrecombinantsarscov2epitopesonthesurfaceinduceshumoralandmucosalimmuneresponsesinmice
AT kyudonghan mucosalimmunizationwithlactiplantibacillusplantarumdisplayingrecombinantsarscov2epitopesonthesurfaceinduceshumoralandmucosalimmuneresponsesinmice
AT larsengstrand mucosalimmunizationwithlactiplantibacillusplantarumdisplayingrecombinantsarscov2epitopesonthesurfaceinduceshumoralandmucosalimmuneresponsesinmice
AT daekyungkang mucosalimmunizationwithlactiplantibacillusplantarumdisplayingrecombinantsarscov2epitopesonthesurfaceinduceshumoralandmucosalimmuneresponsesinmice